publication . Other literature type . 2014

Breakthrough pain - management and treatment

Lončarić-Katušin, Mirjana;
Open Access Croatian
  • Published: 01 Jan 2014 Journal: Medicus, volume 23, issue 2. Liječenje boli (issn: 1330-013X, eissn: 1848-8315, Copyright policy)
  • Publisher: PLIVA CROATIA d.o.o.
Abstract
Probijajuća bol (PB) kod karcinoma definira se kao tranzitorna egzacerbacija boli kod bolesnika sa stabilnom i kontroliranom osnovnom boli. PB i osnovna bol odvojene su komponente karcinomske boli i zahtijevaju odvojen terapijski pristup. Liječenje PB-a uključuje interdisciplinarni i multimodalni pristup. Uobičajeno liječenje PB-a provodi se dodatnim dozama opioida, poznatim kao spasonosna medikacija.
Subjects
free text keywords: karcinomska bol; opioidi; probijajuća bol, cancer pain; opioids; breakthrough pain

PortenoyRK,HagenNA.Breakthroughpain:denfiition,prevalenceand characteristics. Pain 1990;41:273-81.

Portenoy RK, Payne D, Jacobsen P. Breakthrough pain: characteristics and impact in patients with cancer pain. Pain 1999;81:129-34. [OpenAIRE]

Bennett D, Burton AW, Fishman S i sur. Consensus panel recommendations for the assessment and management of breakthrough pain. Part 1: assessment. Pharm Therap 2005;30:296-301.

Bennett D, Burton AW, Fishman S i sur. Consensus panel recommendations for the assessment and management of breakthrough pain. Part 2: Management. Pharm Therap 2005;30:354-61.

Mercadante S, Radbruch L, Caraceni A i sur. Episodic (breakthrough) pain:consensusconferenceofanexpertworkinggroupoftheEuropean Association for Palliative Care. Cancer 2002;94:832-9. [OpenAIRE]

6. Davies AN, Dickman A, Reid C i sur. The management of cancer-related breakthrough pain: recommendations of a task group of the Science Committee of the Association for Palliative Medicine of Great Britain and Ireland. Eur J Pain 2009;13:331-8.

7. Svendsen KB, Andersen S, Arnason S i sur. Breakthrough pain in malignant and non-malignant diseases: a review of prevalence, characteristics and mechanisms. Eur J Pain 2005;9:195-206.

8. Lossignol DA, Dumitrescu C. Breakthrough pain: progress in management. Curr Opin Oncol 2010;22:302-6. [OpenAIRE]

9. Mercadante S. The use of rapid onset opioids for breakthrough cancer pain: the challenge of its dosing. Crit Rev Oncol Hematol 2011;80:460-5. [OpenAIRE]

10. Zeppetella G. Evidence-Based Treatment of Cancer-Related Breakthrough Pain With Opioids. J Natl Compr Netw 2013;11Supl1:S37-43. [OpenAIRE]

11. ZeppetellaG.OpioidsforthemanagementofbreakthroughCancerpain in adults: A systemic review undertaken as part of EPCRC opioid guidelines project. Palliat Med 2010;25:516-24.

Prim. dr. Mirjana Lončarić-Katušin OB Karlovac, Služba za anesteziologiju 47000 Karlovac, Andrije Štampara 3 e-mail: mikatusi@inet.hr

Powered by OpenAIRE Research Graph
Any information missing or wrong?Report an Issue